Since the start of the coronavirus disease 2019 (COVID-19) pandemic in 2020, the global scientific and medical communities...
Auteur - American Diabetes Association - Care
Response to Comment on Celis-Morales et al. Type 2 Diabetes, Glycemic...
We appreciate the interest by Meng and Wang (1) in our article (2), which highlights the need to conduct a competing risk...
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of...
A recent issue of Diabetes Care included a population-based case-control study by Bezin et al. (1) that has set off an alarm...
Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA...
We were interested in the recent article in Diabetes Care from Tang et al. (1), in which they reported that lower HbA1c in...
Phenotypes Associated With Zones Defined by Area Under the Curve...
OBJECTIVEMetabolic zones were developed to characterize heterogeneity of individuals with islet autoantibodies.RESEARCH...
Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to...
OBJECTIVEBasal insulin Fc (BIF) (insulin efsitora alfa; LY3209590), a fusion protein combining a novel single-chain insulin...
Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second...
OBJECTIVETo assess the real-world cardiovascular (CV) safety for sulfonylureas (SU), in comparison with dipeptidyl peptidase...
Earlier Age at Type 2 Diabetes Diagnosis Is Associated With Increased...
OBJECTIVEWe investigated genetic risk of cardiovascular disease (CVD) by age at type 2 diabetes (T2D) diagnosis.RESEARCH...
Development and Validation of a Diabetic Retinopathy Risk...
OBJECTIVEAlthough diabetic retinopathy is a leading cause of blindness worldwide, diabetes-related blindness can be...
CRP, C-Peptide, and Risk of First-Time Cardiovascular Events and...
OBJECTIVEWe investigated the relationship between hs-CRP, a marker of low-grade inflammation, alone or in combination with C...